NACI Recommendations, Statements and Updates (A-Z Index)

Bacille Calmette Guérin (BCG)

• Statement on Bacille Calmette Guérin (BCG) Vaccine - 1 December 2004
• Erratum

Canadian Immunization Guide

• Canadian Immunization Guide, Seventh Edition, 2006

For print copies of the Guide, contact:
Publishing and Depository Services
Public Works and Government Services Canada
Ottawa, Ontario  K1A 0S5
Telephone: 613-941-5995 or 1-800-635-7943
Fax: 613-954-5779 or 1-800-565-7757
E-mail: publications@pwgsc.gc.ca
Web: http://publications.gc.ca

Cochlear Implant Recipients

• Immunization Recommendations for Cochlear Implant Recipients - 1 April 2003

Haemophilus Influenzae Type B

• Statement on the recommended use of pentavalent and hexavalent vaccines 1 February 2007
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age  (2005)

Hepatitis

• Statement on the recommended use of pentavalent and hexavalent vaccines 1 February 2007
• Update To The 2002 Canadian Immunization Guide - 13 May 2004
• Update on hepatitis A vaccine (AVAXIM®, Aventis Pasteur) - 15 October 2001
• Supplementary Statement on Hepatitis A Vaccine - 1 July 2000
• Statement on Alternate Adolescent Schedule for Hepatitis B Vaccine - 1 July 2000
• Statement on combination vaccines against hepatitis A and hepatitis B - 1 June 1999
• Supplementary statement on hepatitis prevention - hepatitis A and hepatitis B combination vaccine for children - 1 June 1999

Human Papillomavirus

• Statement on Human Papillomavirus Vaccine - 15 February 2007

Immunization

• Evidence-based recommendations for immunization – Methods of the National Advisory Committee on Immunization - January 2009

Immunization Schedules

• Immunization Schedules for Children & Adults

Influenza

• Statement on Influenza Vaccination for the 2007-2008 Season - 1 July 2007
• Statement On Influenza Vaccination for The 2006-2007 Season
  - 15 June 2006
• Update on Influenza Vaccination For The 2005-2006 Season - 1 March 2006
• Update on Influenza Vaccination for the 2005-2006 Season - 1 November 2005
• Statement on Influenza Vaccination for the 2005-2006 Season - 15 June 2005
• Statement on Influenza Vaccination for the 2004-2005 Season - 15 June 2004
• Update: Statement on Influenza Vaccination for the 2003-04 Season - 1 March 2004
• Statement on Influenza Vaccination for the 2003-2004 Season - 15 August 2003
• Supplementary Statement for the 2002-2003 Influenza Season: Update on Oculo-respiratory Syndrome in Association with Influenza Vaccination - 1 September 2002
• Statement on Influenza Vaccination for the 2002-2003 Season - 1 August 2002
• Supplementary Statement for The 2001-2002 Season: Influenza Vaccination of Persons Who Experienced Oculo-Respiratory Syndrome Following Previous Influenza Vaccination (ACS-7) - 15 November 2001
• Statement on Influenza Vaccination for the 2001-2002 Season (ACS-4) - 1 August 2001
• Supplementary statement on influenza vaccination: continued use of Fluviral® influenza vaccine in the 2000-2001 season (ACS-1) - 15 January 2001
• Statement on Influenza Vaccination for the 2000-2001 Season - 1 June 2000

Meningococcal Disease

• Meningococcal C Conjugate for Infants statement - November 2007
• Statement on Conjugate meningococcal Vaccine for Serogroups A,C, Y and W135 - 1 May 2007
• Update on Meningococcal C Conjugate Vaccines - 15 April 2005
• Supplementary Statement on Conjugate Meningococcal Vaccines - 1 September 2003
• Statement on Recommended Use of Meningococcal Vaccines - 15 October 2001

Pertussis, Tetanus, and Diphtheria

• Statement on the recommended use of pentavalent and hexavalent vaccines 1 February 2007
• Interval Between Administration of Vaccines Against Diphtheria, Tetanus, and Pertussis - 15 October 2005
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age  - 1 February 2005
• Clarification - Prevention of Pertussis in Adolescents and Adults - 15 March 2004
• Prevention of Pertussis in Adolescents and Adults - 1 September 2003
• Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine - 1 May 2000

Pneumococcus

• Update On the Recommendations For The Routine Use of Pneumococcal Conjugate Vaccine For Infants - 1 May 2006
• Recommendations for use of Pneumococcal 23-Valent Polysaccharide Vaccine During Shortage - 15 August 2004
• Statement on the Recommended Use of Pneumococcal Conjugate Vaccine: Addendum - 15 September 2003
• Statement On Recommended Use Of Pneumococcal Conjugate Vaccine - 15 January 2002

Poliomyelitis

• Statement on the recommended use of pentavalent and hexavalent vaccines 1 February 2007
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age  (2005)

Rabies Vaccines

• Update on Rabies Vaccines - 1 June 2005

Respiratory Syncytial Virus (RSV)

• Statement on the Recommended Use of Monoclonal Anti-RSV Antibody (Palivizumab) - 15 September 2003

Typhoid

• Update To The 2002 Canadian Immunization Guide - Typhoid Vaccine
  1 May 2003

Smallpox

• Statement on Smallpox Vaccination - 15 January 2002

Thimerosal in Vaccines

• Updated Recommendations on the use of Thimerosal-Containing Vaccines in Canada - 1 December 2005
• Statement on Thimerosal - 1 March 2003
• Thimerosal in Vaccines - 1 December 1999

Varicella

• Varizig™ as the varicella zoster immune globulin for the prevention of varicella In at-risk patients (October 15, 2006)
• Update on Varicella - 1 February 2004
• NACI Update to Statement on Varicella Vaccine - 15 February 2002
• Statement on Recommended Use of Varicella Virus Vaccine - 1 May 1999